Literature DB >> 26712261

Multi-organ resection for locally advanced adrenocortical cancer: surgical strategy and literature review.

F Guida, M Clemente, L Valvano, C Napolitano.   

Abstract

Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy with an estimated worldwide incidence of 0.5-2 per million/year. Complete surgical removal of ACC represents the current treatment of choice for this tumor. A disease-free resection margin (R0) is an important predictor of long-term survival: surgery is demanding and must be performed by a highly experienced surgical team. We report the surgical strategy adopted in a patient with locally advanced ACC and virilization to obtain a R0 resection.

Entities:  

Mesh:

Year:  2015        PMID: 26712261      PMCID: PMC4711980          DOI: 10.11138/gchir/2015.36.5.225

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  26 in total

Review 1.  Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.

Authors:  Teresa M Seccia; Ambrogio Fassina; Gastone G Nussdorfer; Achille C Pessina; Gian Paolo Rossi
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

Review 2.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

Review 3.  Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature.

Authors:  Laurent Chiche; Bertrand Dousset; Edouard Kieffer; Yves Chapuis
Journal:  Surgery       Date:  2006-01       Impact factor: 3.982

4.  Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Authors:  Alfredo Berruti; Massimo Terzolo; Paola Sperone; Anna Pia; Silvia Della Casa; David J Gross; Carlo Carnaghi; Paolo Casali; Francesco Porpiglia; Franco Mantero; Giuseppe Reimondo; Alberto Angeli; Luigi Dogliotti
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 5.  Adrenocortical carcinoma with intracaval extension.

Authors:  S P Hedican; F F Marshall
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

6.  Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.

Authors:  Ricardo J Gonzalez; Eric P Tamm; Chaan Ng; Alexandria T Phan; Rena Vassilopoulou-Sellin; Nancy D Perrier; Douglas B Evans; Jeffrey E Lee
Journal:  Surgery       Date:  2007-11-05       Impact factor: 3.982

Review 7.  The optimal imaging of adrenal tumours: a comparison of different methods.

Authors:  Ioannis Ilias; Anju Sahdev; Rodney H Reznek; Ashley B Grossman; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

8.  An eleven-year experience with adrenocortical carcinoma.

Authors:  R F Pommier; M F Brennan
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

9.  The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group.

Authors:  F Crucitti; R Bellantone; A Ferrante; M Boscherini; P Crucitti
Journal:  Surgery       Date:  1996-02       Impact factor: 3.982

Review 10.  Adrenocortical cancer treatment.

Authors:  A Patalano; V Brancato; F Mantero
Journal:  Horm Res       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.